Early administration of Fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients

References

• Dart RC, McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann Emerg Med. 2001;37:181–188.
   PubMed Web of Science ®Google Scholar
• Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161:2030–2036.
   PubMed Web of Science ®Google Scholar
• Dart RC, Seifert SA, Carroll L, et al. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997;30:33–39.
   PubMed Web of Science ®Google Scholar
• Lavonas EJ, Gerardo CJ, O'Malley G, et al. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med. 2004;43:200–206.
   PubMed Web of Science ®Google Scholar
• Offerman SR, Bush SP, Moynihan JA, et al. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation. Pediatrics 2002;110:968–971.
   PubMed Web of Science ®Google Scholar
• Pizon AF, Riley BD, LoVecchio F, et al. Safety and efficacy of Crotalidae Polyvalent Immune Fab in pediatric crotaline envenomations. Acad Emerg Med. 2007;14:373–376.
   PubMed Web of Science ®Google Scholar
• Ruha AM, Curry SC, Beuhler M, et al. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med. 2002;39:609–615.
   PubMed Web of Science ®Google Scholar
• Gerardo CJ, Quackenbush E, Lewis B, et al. The efficacy of crotalidae polyvalent immune Fab (Ovine) antivenom versus placebo plus optional rescue therapy on recovery from copperhead snake envenomation: a randomized, double-blind, placebo-controlled, clinical trial. Ann Emerg Med. 2017;70:233–244.e3.
   PubMed Web of Science ®Google Scholar
• Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med. 2002;347:347–356.
   PubMed Web of Science ®Google Scholar
• Lavonas EJ, Ruha A-M, Banner W, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011;11:2.
   PubMedGoogle Scholar
• Kanaan NC, Ray J, Stewart M, et al. Wilderness Medical society practice guidelines for the treatment of pitviper envenomations in the United States and Canada. Wilderness. Environ Med. 2015;26:472–487.
   Google Scholar
• Gerardo CJ, Scott Evans C, Kuchibhatla M, et al. Time to antivenom administration is not associated with total antivenom dose administered in a copperhead-predominant snakebite population. Acad Emerg Med. 2015;22:308–314.
   PubMed Web of Science ®Google Scholar
• Weant KA, Bowers RC, Reed J, et al. Safety and cost-effectiveness of a clinical protocol implemented to standardize the use of Crotalidae polyvalent immune Fab antivenom at an academic medical center. Pharmacotherapy. 2012;32:433–440.
   PubMed Web of Science ®Google Scholar
• Hefford C, Abbott JH, Arnold R, et al. The patient-specific functional scale: validity, reliability, and responsiveness in patients with upper extremity musculoskeletal problems. J Orthop Sports Phys Ther. 2012;42:56–65.
   PubMed Web of Science ®Google Scholar
• Nicholas P, Hefford C, Tumilty S. The use of the patient-specific functional scale to measure rehabilitative progress in a physiotherapy setting. J Manual Manipulative Therapy. 2012;20:147–152.
   PubMedGoogle Scholar
• Koehorst ML, van Trijffel E, Lindeboom R. Evaluative measurement properties of the patient-specific functional scale for primary shoulder complaints in physical therapy practice. J Orthop Sports Phys Ther. 2014;44:595–603.
   PubMed Web of Science ®Google Scholar
• Anderson VE, Burnham RI, Gillman SM, et al. Validation of patient specific functional scale in copperhead snakebite patients. Clin Toxicol. 2015;53(7):686.
   Web of Science ®Google Scholar
• Bucaretchi F, Herrera SR, Hyslop S, et al. Snakebites by Bothrops spp in children in Campinas, São Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 2001;43:329–333.
   PubMedGoogle Scholar
• Nicoleti AF, Medeiros CR, Duarte MR, FO F. Comparison of Bothropoides jararaca bites with and without envenoming treated at the Vital Brazil Hospital of the Butantan Institute, State of Sao Paulo, Brazil. Rev Soc Bras Med Trop. 2010;43:657–661.
   PubMed Web of Science ®Google Scholar
• Santoro ML, Sano-Martins IS, Fan HW, et al. Haematological evaluation of patients bitten by the jararaca, Bothrops jararaca, in Brazil. Toxicon. 2008;51:1440.
   PubMed Web of Science ®Google Scholar
• Pinho FM, Zanetta DM, Burdmann EA. Acute renal failure after Crotalus durissus snakebite: a prospective survey on 100 patients. Kidney Int. 2005;67:659–667.
   PubMed Web of Science ®Google Scholar
• Bucaretchi F, Herrera SR, Hyslop S, et al. Snakebites by Crotalus durissus ssp in children in Campinas, São Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 2002;44:133–138.
   PubMedGoogle Scholar
• Otero R, Gutierrez J, Beatriz Mesa M, et al. Complications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital. Toxicon 2002;40:1107–1114.
   PubMed Web of Science ®Google Scholar
• Thomas L, Tyburn B, Ketterle J, et al. Prognostic significance of clinical grading of patients envenomed by Bothrops lanceolatus in Martinique. Members of the Research Group on Snake Bite in Martinique. Trans Roy Soc Trop Med Hyg. 1998;92:542–545.
   PubMed Web of Science ®Google Scholar
• Ribeiro LA, Jorge MT, Lebrao ML. Prognostic factors for local necrosis in Bothrops jararaca (Brazilian pit viper) bites. Trans R Soc Trop Med Hyg. 2001;95:630–634.
   PubMed Web of Science ®Google Scholar